← All In8bio, INC filings

In8bio, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
INAB
In8bio, INC
DEF: IN8bio Seeks Shareholder Approval for Equity Plan Expansion
IN8bio, Inc. has filed a definitive proxy statement for its 2026 Annual Meeting of Stockholders, seeking approval for director elections, auditor ratification, and a significant increase in its equity incentive plan share reserve.
NASDAQ
INAB
In8bio, INC
DEFR14A: IN8bio Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
IN8bio is asking stockholders to approve a reverse stock split to maintain its listing on the Nasdaq Capital Market and potentially improve stock marketability.
NASDAQ
INAB
In8bio, INC
DEFA14A: IN8bio, Inc. to Hold Annual Stockholders Meeting, Proposes Reverse Stock Split
IN8bio, Inc. will hold its annual stockholders meeting on May 8, 2025, to elect directors, ratify the selection of an accounting firm, and vote on a potential reverse stock split.
NASDAQ
INAB
In8bio, INC
DEF: IN8bio Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
IN8bio is asking stockholders to approve a reverse stock split to maintain its listing on the Nasdaq Capital Market and potentially improve stock marketability.
NASDAQ
INAB
In8bio, INC
DEFA14A: IN8bio, Inc. to Hold Annual Stockholders Meeting on June 12, 2024
IN8bio, Inc. will hold its annual stockholders meeting on June 12, 2024, to elect directors and ratify the selection of its accounting firm.
NASDAQ
INAB
In8bio, INC
DEF 14A: IN8bio Seeks Stockholder Approval for Director Elections and Accounting Firm Ratification at 2024 Annual Meeting
IN8bio, Inc. is holding its 2024 Annual Meeting of Stockholders virtually on June 12, 2024, to elect directors and ratify the selection of its independent accounting firm.